Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling
- PMID: 26126266
- PMCID: PMC4484057
- DOI: 10.7554/eLife.07091
Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling
Abstract
Wnt signaling is essential for tissue homeostasis and its dysregulation causes cancer. Wnt ligands trigger signaling by activating Frizzled receptors (FZDRs), which belong to the G-protein coupled receptor superfamily. However, the mechanisms of G protein activation in Wnt signaling remain controversial. In this study, we demonstrate that FZDRs activate G proteins and trigger non-canonical Wnt signaling via the Dishevelled-binding protein, Daple. Daple contains a Gα-binding and activating (GBA) motif, which activates Gαi proteins and an adjacent domain that directly binds FZDRs, thereby linking Wnt stimulation to G protein activation. This triggers non-canonical Wnt responses, that is, suppresses the β-catenin/TCF/LEF pathway and tumorigenesis, but enhances PI3K-Akt and Rac1 signals and tumor cell invasiveness. In colorectal cancers, Daple is suppressed during adenoma-to-carcinoma transformation and expressed later in metastasized tumor cells. Thus, Daple activates Gαi and enhances non-canonical Wnt signaling by FZDRs, and its dysregulation can impact both tumor initiation and progression to metastasis.
Keywords: G proteins; GEF; PI3K/Akt; Rac1; biophysics; cell biology; human; structural biology; tumor suppressor.
Conflict of interest statement
The authors declare that no competing interests exist.
Figures
References
-
- Akhurst RJ, Derynck R. TGF-beta signaling in cancer—a double-edged sword. Trends in Cell Biology. 2001;11:S44–S51. - PubMed
-
- Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research. 1987;47:3239–3245. - PubMed
-
- Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long GV, von Euw EM, Yang PT, Chen HW, Haydu L, Toroni RA, Lucero OM, Chien AJ, Moon RT. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. The Journal of Clinical Investigation. 2014;124:2877–2890. doi: 10.1172/JCI70156. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
